Log in
Pharmacology · Drugs and Prescriptions

Sodium valproate

Natrii valproas

Sodium valproate (the sodium salt of valproic acid) is a broad-spectrum antiepileptic drug belonging to agents affecting the central nervous system. It features a combined mechanism of action, due to which it effectively suppresses seizure activity in almost all forms of epilepsy.

Pharmacological groupAgents acting on the central nervous system (antiepileptics)
Main targetsSodium and calcium channels, GABA system
Dosage form0.3 g tablets
Special noteContraindicated in liver and pancreas pathologies
How to write a prescription
Rp.: Tab. Natrii valproatis 0,3
D.t.d. N 50
S. Внутрь по 1 таблетке 2-3 раза в сутки во время или сразу после еды, не разжевывая

Alternative spellings: Tabulettas Natrii valproatis 0.3; Tab. Natrii valproatis 0.3 obductas; Tab. "Depakine" 0.3

Dosage form
Tab. 0.3 g
Administration
Oral, 0.3 g during or immediately after meals, without chewing, 2–3 times a day
Group
Agents affecting the central nervous system
4 min readFor medical studentsUpdated 09/24/2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Classification position

Antiepileptic drugs are divided into groups depending on the pathogenetic link they affect. Valproic acid and its salts belong to agents with a combined mechanism of action (topiramate is also included in this group).

Due to their polyvalent effect, such drugs are difficult to assign to a single specific narrow group. For comparison, there are drugs with a more targeted action:

  • Voltage-gated sodium channel blockers (phenytoin, carbamazepine, lamotrigine).
  • Agents enhancing GABAergic inhibition (barbiturates, benzodiazepines, vigabatrin).
  • T-type calcium channel blockers (ethosuximide).
  • Agents inhibiting the action of excitatory amino acids (felbamate).

Valproates combine several of the listed effects at once, which justifies their classification into a separate pharmacological subgroup.

Mechanism of action (Pharmacodynamics)

The polyvalent effect of the drug consists of three main components (the so-called "triple effect"):

  1. Blockade of voltage-gated sodium ($Na^+$) channels. The drug acts on the presynaptic membrane, suppressing high-frequency neuronal discharges directly in the epileptogenic focus. This stabilizes the membrane and prevents the spread of pathological excitation.
  2. Enhancement of GABAergic inhibition. Valproates increase the content of the main inhibitory neurotransmitter of the central nervous system — GABA (gamma-aminobutyric acid). This occurs due to two opposing processes:
  3. Inhibition of catabolism: blockade of the GABA transaminase enzyme reduces the breakdown of the neurotransmitter.
  4. Stimulation of synthesis: increasing the activity of the glutamate decarboxylase enzyme accelerates the formation of GABA.
  5. Blockade of T-type calcium ($Ca^{2+}$) channels. The target is localized on the postsynaptic membrane (often associated with thalamic neurons). This mechanism is specifically important for suppressing minor seizures (absence seizures).
Test your knowledge on the topicTasks from the «Pharmacology» course bank — instant answers and explanations.

Pharmacokinetics

When administered orally, the drug demonstrates good absorption in the gastrointestinal tract. The maximum concentration in blood plasma is reached on average in 2 hours (the exact time may vary depending on the specific dosage form). It is metabolized in the body and excreted by the kidneys as oxidation products or conjugates with glucuronic acid (glucuronides).

Indications for use

Due to its broad spectrum of activity, sodium valproate is effective in almost all forms of epilepsy. The main indications include:

  • Generalized seizures (both major convulsive / tonic-clonic and minor / absence seizures).
  • Partial (focal) seizures.
  • Myoclonic epilepsy.

Side effects and contraindications

The safety profile of valproates requires careful monitoring of the patient's condition. The following adverse reactions are possible:

  • Gastrointestinal tract: dyspeptic disorders (nausea, vomiting, diarrhea, stomach pain).
  • Central nervous system: drowsiness, tremor, ataxia, nystagmus, and diplopia (double vision).
  • Blood system: impaired blood clotting, thrombocytopenia, anemia.
  • Allergic reactions: various skin manifestations.

Contraindications: The drug is strictly prohibited in pronounced liver function disorders, as well as in pancreatic function disorders.

Dosage form and administration rules

In clinical practice, both valproic acid itself and its sodium salt are used. Well-known trade names: Acediprol, Apilepsin, Depakine.

  • Dosage form: 0.3 g tablets.
  • Dosing regimen: Oral, 0.3 g 2–3 times a day.
  • Administration features: Take during or immediately after meals. The tablet must be swallowed whole without chewing to minimize the irritating effect on the gastrointestinal mucosa.

Briefly: answers to topical questions

What are the features of metabolism and pharmacogenetics of valproates in the liver?

The metabolism of valproic acid occurs with the formation of conjugates and oxidation products, while the drug has direct hepatotoxic potential. Features of metabolism and effects on the liver include:

  • Metabolism — excreted by the kidneys as conjugates with glucuronic acid (glucuronides) or oxidation products.
  • Hepatotoxicity — the drug can directly damage key metabolic pathways in hepatocytes, disrupting their functions.
  • Risk factors — the risk of drug-induced liver injury from valproic acid is increased in young people, as well as with regular heavy alcohol consumption.
  • Contraindications — pronounced liver function disorders.
How to memorize

Valproate's triple hit: closed Na-channels (no major seizures), closed T-type Ca-channels (no absence seizures), accumulated GABA (calmed the brain).

Class and exam questions

Why are valproates effective in both major and minor seizures?

This is due to the combined mechanism of action. Sodium channel blockade suppresses major convulsive seizures, while blockade of T-type calcium channels on the postsynaptic membrane stops minor seizures (absence seizures).

How does the drug affect the GABA system?

It acts from two sides: it blocks the GABA transaminase enzyme (stopping GABA breakdown) and stimulates glutamate decarboxylase (accelerating GABA synthesis).

Which organs are most vulnerable to the toxic effects of valproates?

Liver and pancreas. Pronounced disorders of their function are an absolute contraindication to prescribing the drug.

Something unclear? Ask the AIThe AI tutor has reviewed the material on "Sodium valproate" and will explain it in simple terms.

What else to study on this topic

  • Classification of antiepileptic drugs by pathogenetic link.
  • Differences between valproates and pure sodium channel blockers (phenytoin, carbamazepine).
  • The role of T-type calcium channels in the pathogenesis of absence seizures.
  • GABA metabolism in the central nervous system (the role of GABA transaminase).
  • Comparative characteristics of valproic acid and ethosuximide.

Master the entire topic in the «Pharmacology» course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "Sodium valproate" and 5,304 more pages of the subject
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 116 video lessons on the subject

Other topics in the «Drugs and Prescriptions» section

The entire "Drugs and Prescription" section

Free video lessons: pharmacologyShort lessons with study notes — no registration required.

Watch lessons

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.